companydata.dkAmicus Therapeutics ApS: Financial statements 2018
CVR: 39359340
Amicus Therapeutics ApS (CVR 39359340) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,979,408 and a net result of DKK 73,533. Equity amounted to DKK 123,533. The solvency ratio was 6.2%. The company had 2 employees in the financial year.
- Gross Profit
- 1,979,408 kr.
- Profit/Loss
- 73,533 kr.
- Equity
- 123,533 kr.
- Total Assets
- 1,979,408 kr.
- Employees
- 2
Keep an eye on Amicus Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of July 6, 2018, Detlef Wolff has joined the board of directors of Amicus Therapeutics ApS.
As of July 6, 2018, Lori Mochan has joined the board of directors of Amicus Therapeutics ApS.
As of July 6, 2018, Jasvinder Sarkaria has left the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Johnny Krogh Hansen has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Simon Collins has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Jasvinder Sarkaria has joined the board of directors of Amicus Therapeutics ApS.
As of February 23, 2018, Johnny Krogh Hansen is registered as director of Amicus Therapeutics ApS.
As of February 23, 2018, is registered as an owner of Amicus Therapeutics ApS with an ownership share of 100%.
Amicus Therapeutics ApS was founded on February 23, 2018.
About Amicus Therapeutics ApS
Amicus Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Richard Gideon Morris. The company is owned by Amicus Therapeutics UK Ltd.. The company has 2 employees. In 2025, the company reported a gross profit of DKK 1,441,140 and a net result of DKK 115,004 compared with DKK 16,475 the year before. Equity amounted to DKK 424,641.